HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McKesson launches "Trial Script" pharmacy-dispensed sampling program with Axid, Prozac, Lotensin.

Executive Summary

MCKESSON "TRIAL SCRIPT" ELECTRONIC SAMPLING PILOT PROGRAM includes Lilly's Axid and Prozac and Ciba's Lotensin and Lotensin HCT, the McKesson subsidiary Healthcare Delivery Systems announced Aug. 8. The pharmacy-based alternative to physician-dispensed sampling involves manufacturer distribution of "Trial Script" stickers or certificates in lieu of actual product samples. Patients who bring a prescription with a Trial Script identifier will be dispensed a free starter sample of the prescription. Program implementation was expected the week of Aug. 7, HDS said.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026687

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel